The stent graft barnacle - edge hyperplasia following femoral artery implant in a young female

A 37-year-old female underwent an emergent implant of a covered self-expandable stent graft (8mm x 10cm Viabahn, W. L. Gore) due to acute bleeding from a femoral access following closure of a patent foramen ovale. Over the following months, intermittent claudication developed, progressively more incapacitant. Work-up revealed near-occlusion of the stent graft due to edge stenosis. Elective explant of the stent graft was performed, revealing extensive proximal and distal edge miointimal hyperplasia (marked with *). Endarterectomy was performed and the arterial defect was corrected with a bovine pericardium patch

Aneurysm Sac Dynamics and its Prognostic Significance Following Fenestrated and Branched Endovascular Aortic Aneurysm Repair

Objective: This study aimed to assess aneurysm sac dynamics and its prognostic significance following fenestrated and branched endovascular aneurysm repair (F/BEVAR). Methods: Patients undergoing F/BEVAR for degenerative complex aortic aneurysm from 2008 to 2020 at two large vascular centres with two imaging examinations (30 day and one year) were included. Patients were categorised as regression and non-regression, determined by the proportional volume change (&gt; 5%) at one year compared with 30 days. All cause mortality and freedom from graft related events were assessed using Kaplan–Meier methods. Factors associated with non-regression at one year and aneurysm sac volume over time were examined for FEVAR and BEVAR independently using multivariable logistic regression and linear mixed effects modelling. Results: One hundred and sixty-five patients were included: 122 FEVAR, of whom 34% did not regress at one year imaging (20% stable, 14% expansion); and 43 BEVAR, of whom 53% failed to regress (26% stable, 28% expansion). Following F/BEVAR, after risk adjusted analysis, non-regression was associated with higher risk of all cause mortality within five years (hazard ratio [HR] 2.56, 95% confidence interval [CI] 1.09 – 5.37; p = .032) and higher risk of graft related events within five years (HR 2.44, 95% CI 1.10 – 5.26; p = .029). Following multivariable logistic regression, previous aortic repair (odds ratio [OR] 2.56, 95% CI 1.11 – 5.96; p = .029) and larger baseline aneurysm diameter (OR/mm 1.04, 95% CI 1.00 – 1.09; p = .037) were associated with non-regression at one year, whereas smoking history was inversely associated with non-regression (OR 0.21, 95% CI 0.04 – 0.96; p = .045). Overall following FEVAR, aneurysm sac volume decreased significantly up to two years (baseline vs. two year, 267 [95% CI 250 – 285] cm 3 vs. 223 [95% CI 197 – 248] cm 3), remaining unchanged thereafter. Overall following BEVAR, aneurysm sac volume remained stable over time. Conclusion: Like infrarenal EVAR, non-regression at one year imaging is associated with higher five year all cause mortality and graft related events risks after F/BEVAR. Following FEVAR for juxtarenal aortic aneurysm, aneurysm sacs generally displayed regression (66% at one year), whereas after BEVAR for thoraco-abdominal aortic aneurysm, aneurysm sacs displayed a concerning proportion of growth at one year (28%), potentially suggesting a persistent risk of rupture and consequently requiring intensified surveillance following BEVAR. Future studies will have to elucidate how to improve sac regression following complex EVAR, and whether the high expansion risk after BEVAR is due to advanced disease extent.</p

Aneurysm Sac Dynamics and its Prognostic Significance Following Fenestrated and Branched Endovascular Aortic Aneurysm Repair

Objective: This study aimed to assess aneurysm sac dynamics and its prognostic significance following fenestrated and branched endovascular aneurysm repair (F/BEVAR). Methods: Patients undergoing F/BEVAR for degenerative complex aortic aneurysm from 2008 to 2020 at two large vascular centres with two imaging examinations (30 day and one year) were included. Patients were categorised as regression and non-regression, determined by the proportional volume change (&gt; 5%) at one year compared with 30 days. All cause mortality and freedom from graft related events were assessed using Kaplan–Meier methods. Factors associated with non-regression at one year and aneurysm sac volume over time were examined for FEVAR and BEVAR independently using multivariable logistic regression and linear mixed effects modelling. Results: One hundred and sixty-five patients were included: 122 FEVAR, of whom 34% did not regress at one year imaging (20% stable, 14% expansion); and 43 BEVAR, of whom 53% failed to regress (26% stable, 28% expansion). Following F/BEVAR, after risk adjusted analysis, non-regression was associated with higher risk of all cause mortality within five years (hazard ratio [HR] 2.56, 95% confidence interval [CI] 1.09 – 5.37; p = .032) and higher risk of graft related events within five years (HR 2.44, 95% CI 1.10 – 5.26; p = .029). Following multivariable logistic regression, previous aortic repair (odds ratio [OR] 2.56, 95% CI 1.11 – 5.96; p = .029) and larger baseline aneurysm diameter (OR/mm 1.04, 95% CI 1.00 – 1.09; p = .037) were associated with non-regression at one year, whereas smoking history was inversely associated with non-regression (OR 0.21, 95% CI 0.04 – 0.96; p = .045). Overall following FEVAR, aneurysm sac volume decreased significantly up to two years (baseline vs. two year, 267 [95% CI 250 – 285] cm 3 vs. 223 [95% CI 197 – 248] cm 3), remaining unchanged thereafter. Overall following BEVAR, aneurysm sac volume remained stable over time. Conclusion: Like infrarenal EVAR, non-regression at one year imaging is associated with higher five year all cause mortality and graft related events risks after F/BEVAR. Following FEVAR for juxtarenal aortic aneurysm, aneurysm sacs generally displayed regression (66% at one year), whereas after BEVAR for thoraco-abdominal aortic aneurysm, aneurysm sacs displayed a concerning proportion of growth at one year (28%), potentially suggesting a persistent risk of rupture and consequently requiring intensified surveillance following BEVAR. Future studies will have to elucidate how to improve sac regression following complex EVAR, and whether the high expansion risk after BEVAR is due to advanced disease extent.</p

International variations and sex disparities in the treatment of peripheral arterial occlusive disease : a report from VASCUNET and the International Consortium Of Vascular Registries

Objective: The aim of this study was to determine sex specific differences in the invasive treatment of symptomatic peripheral arterial occlusive disease (PAOD) between member states participating in the VASCUNET and International Consortium of Vascular Registries.Methods: Data on open surgical revascularisation and peripheral vascular intervention (PVI) of symptomatic PAOD from 2010 to 2017 were collected from population based administrative and registry data from 11 countries. Differences in age, sex, indication, and invasive treatment modality were analysed.Results: Data from 11 countries covering 671 million inhabitants and 1 164 497 hospitalisations (40% women, mean age 72 years, 49% with intermittent claudication, 54% treated with PVI) in Europe (including Russia), North America, Australia, and New Zealand were included. Patient selection and treatment modality varied widely for the proportion of female patients (23% in Portugal and 46% in Sweden), the proportion of patients with claudication (6% in Italy and 69% in Russia), patients’ mean age (70 years in the USA and 76 years in Italy), the proportion of octogenarians (8% in Russia and 33% in Sweden), and the proportion of PVI (24% in Russia and 88% in Italy). Numerous differences between females and males were observed in regard to patient age (72 vs. 70 years), the proportion of octogenarians (28% vs. 15%), proportion of patients with claudication (45% vs. 51%), proportion of PVI (57% vs. 51%), and length of hospital stay (7 days vs. 6 days).Conclusion: Remarkable differences regarding the proportion of peripheral vascular interventions, patients with claudication, and octogenarians were seen across countries and sexes. Future studies should address the underlying reasons for this, including the impact of national societal guidelines, reimbursement, and differences in health maintenance.peer-reviewe

PRIMEIRO ANO DO MÓDULO DE ANEURISMA DA AORTA ABDOMINAL DO REGISTO NACIONAL DE PROCEDIMENTOS VASCULARES – IMPLEMENTAÇÃO, RESULTADOS E ORIENTAÇÕES FUTURAS

Introdução: Os registos clínicos são ferramentas fundamentais para a conhecer a realidade e poder auditar o tratamento de aneurismas da aorta abdominal (AAA). A Sociedade Portuguesa de Angiologia e Cirurgia Vascular, promotora do Registo Nacional de Procedimentos Vasculares (RNPV), desenvolveu um módulo para esta patologia que iniciou o seu funcionamento em Dezembro de 2019. O objetivo deste artigo é apresentar dados referentes ao primeiro ano de funcionamento do módulo de AAA. Métodos: O módulo de AAA do RNPV abriu a possibilidade (voluntária) de registo em Dezembro de 2019. Após formação específica aos investigadores, os centros participantes deram início aos registos, de forma progressiva, ao longo do ano de 2020. O registo é realizado numa ferramenta informática especialmente desenvolvida para o efeito. São registados todos os casos de AAA (incluindo justa- ou supra-renais), com ou sem envolvimento das artérias ilíacas, de etiologia degenerativa. São excluídos aneurismas toraco-abdominais e ilíacos isolados. São registados dados demográficos, anatómicos, co-morbilidades, modo de admissão, detalhes sobre o tratamento e seguimento até aos 30-dias/intra- -hospitalar. O seguimento aos 1 ano e 5 anos é opcional. Para a finalidade deste relatório, foram apenas analisados dados referentes ao modo de admissão e tipo de tratamento, assim como a mortalidade aos 30-dias/intra-hospitalar. Resultados: Entre Dezembro de 2019 e Dezembro de 2020, foram registados 350 doentes na plataforma do módulo de AAA do RNPV. A idade média dos doentes registados é de 74.3 ± 13.7 anos, e 92.0% são do sexo masculino. O modo de admissão foi eletivo em 76,9% dos casos. O diâmetro máximo do aneurisma aórtico foi em média 63.9mm ± 19.9mm. A maioria dos doentes apresentava AAA infra-renal, numa percentagem semelhante em casos eletivos e em urgência (79% vs 76%), p=0.16. A indicação para tratamento foi o diâmetro aórtico em 59.4% dos casos. O tratamento endovascular (EVAR) foi utilizado em 68.9% dos casos. Em cirurgia eletiva, a percentagem de EVAR foi 75.7% e em urgência 45.7%, p < 0.01. Em cirurgia eletiva, a mortalidade aos 30 dias ou intra-hospitalar foi de 3.3% (8 doentes). Para doentes tratados por EVAR foi de 2.8% e para cirurgia aberta 5.2%, p<0.01. A mortalidade aos 30 dias ou intra-hospitalar em urgência foi 41.9%, por EVAR foi 20.0% e por cirurgia aberta 61.6%, p<0.01. Conclusão: No primeiro ano de funcionamento, o módulo AAA do RNPV produziu importantes dados que ajudam a compreender os padrões de tratamento desta patologia em Portugal. Estes dados podem ajudar os diferentes Serviços a melhorar a sua prática, através da comparação com os valores de referência gerados

Corrigendum to "European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. [Eur J Vasc Endovasc Surg (2022) 63, 184-267]"

proofepub_ahead_of_prin